MAZE logo

Maze Therapeutics, Inc. (MAZE) EBIT

annual EBIT:

$57.59M+$156.14M(+158.43%)
December 31, 2024

Summary

  • As of today (September 16, 2025), MAZE annual earnings before interest & taxes is $57.59 million, with the most recent change of +$156.14 million (+158.43%) on December 31, 2024.
  • During the last 3 years, MAZE annual EBIT has risen by +$168.61 million (+151.87%).
  • MAZE annual EBIT is now at all-time high.

Performance

MAZE EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEincome statement metrics

quarterly EBIT:

-$36.47M-$1.07M(-3.03%)
June 30, 2025

Summary

  • As of today (September 16, 2025), MAZE quarterly earnings before interest & taxes is -$36.47 million, with the most recent change of -$1.07 million (-3.03%) on June 30, 2025.
  • Over the past year, MAZE quarterly EBIT has dropped by -$176.03 million (-126.14%).
  • MAZE quarterly EBIT is now -126.14% below its all-time high of $139.56 million, reached on June 30, 2024.

Performance

MAZE quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEincome statement metrics

TTM EBIT:

-$125.83M-$176.03M(-350.66%)
June 30, 2025

Summary

  • As of today (September 16, 2025), MAZE TTM earnings before interest & taxes is -$125.83 million, with the most recent change of -$176.03 million (-350.66%) on June 30, 2025.
  • Over the past year, MAZE TTM EBIT has dropped by -$189.09 million (-298.90%).
  • MAZE TTM EBIT is now -295.81% below its all-time high of $64.26 million, reached on September 30, 2024.

Performance

MAZE TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

MAZE EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+158.4%-126.1%-298.9%
3 y3 years+151.9%-44.6%-398.8%
5 y5 years+151.9%-44.6%-398.8%

MAZE EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+151.9%-126.1%at low-295.8%at low
5 y5-yearat high+151.9%-126.1%at low-295.8%at low
alltimeall timeat high+151.9%-126.1%at low-295.8%at low

MAZE EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
-$36.47M(+3.0%)
-$125.83M(-350.7%)
Mar 2025
-
-$35.40M(+19.1%)
$50.20M(-12.8%)
Dec 2024
$57.59M
-$29.73M(+22.7%)
$57.59M(-10.4%)
Sep 2024
-
-$24.23M(-117.4%)
$64.26M(+1.6%)
DateAnnualQuarterlyTTM
Jun 2024
-
$139.56M(-598.2%)
$63.26M(-182.9%)
Mar 2024
-
-$28.01M(+21.5%)
-$76.29M(+58.0%)
Dec 2023
-$98.55M(-11.2%)
-$23.05M(-8.6%)
-$48.28M(+91.4%)
Sep 2023
-
-$25.23M
-$25.23M
Dec 2022
-$111.03M
-
-

FAQ

  • What is Maze Therapeutics, Inc. annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. annual EBIT year-on-year change?
  • What is Maze Therapeutics, Inc. quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. quarterly EBIT year-on-year change?
  • What is Maze Therapeutics, Inc. TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. TTM EBIT year-on-year change?

What is Maze Therapeutics, Inc. annual earnings before interest & taxes?

The current annual EBIT of MAZE is $57.59M

What is the all time high annual EBIT for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high annual earnings before interest & taxes is $57.59M

What is Maze Therapeutics, Inc. annual EBIT year-on-year change?

Over the past year, MAZE annual earnings before interest & taxes has changed by +$156.14M (+158.43%)

What is Maze Therapeutics, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of MAZE is -$36.47M

What is the all time high quarterly EBIT for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $139.56M

What is Maze Therapeutics, Inc. quarterly EBIT year-on-year change?

Over the past year, MAZE quarterly earnings before interest & taxes has changed by -$176.03M (-126.14%)

What is Maze Therapeutics, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of MAZE is -$125.83M

What is the all time high TTM EBIT for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high TTM earnings before interest & taxes is $64.26M

What is Maze Therapeutics, Inc. TTM EBIT year-on-year change?

Over the past year, MAZE TTM earnings before interest & taxes has changed by -$189.09M (-298.90%)
On this page